Copy Number Variations Found in Patients with a Corpus Callosum Abnormality and Intellectual Disability
暂无分享,去创建一个
C. Depienne | A. Toutain | C. Rooryck | D. Lacombe | C. Thauvin-Robinet | D. Ville | V. des Portes | T. Billette de Villemeur | S. Chantot-Bastaraud | J. Siffroi | A. Jacquette | D. Heron | C. Mignot | B. Keren | D. Sanlaville | C. Caignec | A. Faudet | M. Moutard | C. Nava | A. Masurel-Paulet | L. Olivier-Faivre | F. Lesne | S. Whalen | D. Haye | I. Marey | S. Heide | S. Naudion | E. Fonteneau | Corinne Mach | E. Lejeune | A. Masurel‐Paulet | É. Lejeune
[1] D. MacGregor,et al. Corpus callosum abnormalities: neuroradiological and clinical correlations , 2016, Developmental medicine and child neurology.
[2] J. Rosenfeld,et al. Novel features of 3q29 deletion syndrome: Results from the 3q29 registry , 2016, American journal of medical genetics. Part A.
[3] B. Kamien,et al. A familial 7q36.3 duplication associated with agenesis of the corpus callosum , 2015, American journal of medical genetics. Part A.
[4] R. Frausto,et al. Posterior polymorphous corneal dystrophy 3 is associated with agenesis and hypoplasia of the corpus callosum , 2014, Vision Research.
[5] E. Palmer,et al. Agenesis of the corpus callosum: A clinical approach to diagnosis , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[6] A James Barkovich,et al. Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes. , 2014, Brain : a journal of neurology.
[7] Joseph T. Glessner,et al. Both Rare and De Novo Copy Number Variants Are Prevalent in Agenesis of the Corpus Callosum but Not in Cerebellar Hypoplasia or Polymicrogyria , 2013, PLoS genetics.
[8] A. Afenjar,et al. Novel comprehensive diagnostic strategy in Pitt–Hopkins syndrome: Clinical score and further delineation of the TCF4 mutational spectrum , 2012, Human mutation.
[9] Sixto García-Miñaur,et al. Characterization of a 8q21.11 microdeletion syndrome associated with intellectual disability and a recognizable phenotype. , 2011, American journal of human genetics.
[10] C. Ruivenkamp,et al. Genomic and clinical characteristics of six patients with partially overlapping interstitial deletions at 10p12p11 , 2011, European Journal of Human Genetics.
[11] S. Cavani,et al. A 12.4 Mb direct duplication in 19q12-q13 in a boy with cardiac and CNS malformations and developmental delay , 2011, Journal of Applied Genetics.
[12] F. Quintero-Rivera,et al. Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: Case report and review , 2010, American journal of medical genetics. Part A.
[13] J. Clayton-Smith,et al. Identification of genomic loci contributing to agenesis of the corpus callosum , 2010, American journal of medical genetics. Part A.
[14] Leslie G Biesecker,et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.
[15] N. Nukina,et al. A Functional Null Mutation of SCN1B in a Patient with Dravet Syndrome , 2009, The Journal of Neuroscience.
[16] G. Berx,et al. The role of the ZEB family of transcription factors in development and disease , 2009, Cellular and Molecular Life Sciences.
[17] A. Barkovich,et al. Variability of Homotopic and Heterotopic Callosal Connectivity in Partial Agenesis of the Corpus Callosum: A 3T Diffusion Tensor Imaging and Q-Ball Tractography Study , 2008, American Journal of Neuroradiology.
[18] G. Shaw,et al. Agenesis of the corpus callosum in California 1983–2003: A population‐based study , 2008, American journal of medical genetics. Part A.
[19] Uwe Heinrich,et al. Agenesis and dysgenesis of the corpus callosum: Clinical, genetic and neuroimaging findings in a series of 41 patients , 2008, American journal of medical genetics. Part A.
[20] P. Lapunzina,et al. Direct tandem duplication in chromosome 19q characterized by array CGH. , 2008, European journal of medical genetics.
[21] R. Tervo,et al. Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication , 2008, Molecular Cytogenetics.
[22] C. Fuster,et al. Duplication 19q13-qter and deletion 19p13-pter arising from an inversion (19)(p13.3q13.3) of maternal origin. , 2006, European journal of medical genetics.
[23] C. Gélinas,et al. A molecular insight of Hes5‐dependent inhibition of myelin gene expression: old partners and new players , 2006, The EMBO journal.
[24] Gail P Jarvik,et al. Reporting genetic results in research studies: Summary and recommendations of an NHLBI working group , 2006, American journal of medical genetics. Part A.
[25] B. D. de Vries,et al. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. , 2005, American journal of human genetics.
[26] L. W. Wang,et al. Major brain lesions detected on sonographic screening of apparently normal term neonates , 2004, Neuroradiology.
[27] Lori L. Isom,et al. Mice Lacking Sodium Channel β1 Subunits Display Defects in Neuronal Excitability, Sodium Channel Expression, and Nodal Architecture , 2004, The Journal of Neuroscience.
[28] Eric C. Lai,et al. Notch signaling: control of cell communication and cell fate , 2004, Development.
[29] C. Adamsbaum,et al. Agenesis of corpus callosum: prenatal diagnosis and prognosis , 2003, Child's Nervous System.
[30] B. Moore,et al. Quantitative Morphology of the Corpus Callosum in Children With Neurofibromatosis and Attention-Deficit Hyperactivity Disorder , 2000, Journal of child neurology.
[31] B. Barres,et al. Notch Receptor Activation Inhibits Oligodendrocyte Differentiation , 1998, Neuron.
[32] J. Bodensteiner,et al. Evaluation of the child with idiopathic mental retardation. , 1992, Pediatric clinics of North America.
[33] J. Grogono. Children with Agenesis of the Corpus Callosum , 1968, Developmental medicine and child neurology.
[34] M. Lavorgna,et al. A new case of partial trisomy 19q (ql3.2-÷qter) owing to an unusual maternal translocation , 2022 .